Keyphrases
Flumazenil
100%
Hepatic Encephalopathy
100%
Randomized Clinical Trial
100%
Placebo
100%
Cirrhosis
100%
Risk Ratio
31%
Beneficial Effects
31%
Confidence Interval
31%
Risk of Bias
25%
All-cause Mortality
18%
Low Risk
18%
Clinical Analysis
18%
Cochrane
12%
Covert Hepatic Encephalopathy
12%
Hepatobiliary
12%
Harmful Effects
12%
Cause of Death
6%
Embase
6%
Recognition Site
6%
Subgroup Analysis
6%
Clinical Scales
6%
High Affinity
6%
Review Authors
6%
Publication Status
6%
Psychometric Tests
6%
Brain Function
6%
Cirrhosis Complications
6%
Extracted Data
6%
Meta-analysis
6%
High Risk
6%
Non-fatal
6%
MEDLINE
6%
Potential Harm
6%
Sensitivity Analysis
6%
Conference Proceedings
6%
Science Citation Index Expanded
6%
Modulatory Effects
6%
Search Methods
6%
Regression Analysis
6%
Selection Criteria
6%
Overall Assessment
6%
Acute Episodes
6%
γ-aminobutyric Acid
6%
Benzodiazepines
6%
Potential Gains
6%
Bias Control
6%
Serious Adverse Events
6%
Common Complications
6%
Receptor Function
6%
Small-study Effects
6%
Medicine and Dentistry
Randomized Clinical Trial
100%
Hepatic Encephalopathy
100%
Flumazenil
100%
Liver Cirrhosis
100%
Placebo
100%
All Cause Mortality
18%
Sequential Analysis
18%
Psychometry
6%
Meta-Analysis
6%
Benzodiazepine
6%
4 Aminobutyric Acid Receptor
6%
Adverse Event
6%
Subgroup Analysis
6%
Observational Study
6%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Placebo
100%
Randomized Clinical Trial
100%
Hepatic Encephalopathy
100%
Flumazenil
100%
All Cause Mortality
18%
Adverse Event
6%
Benzodiazepine Receptor Blocking Agent
6%
4 Aminobutyric Acid Receptor
6%
Benzodiazepine
6%
Observational Study
6%
Biochemistry, Genetics and Molecular Biology
Randomized Clinical Trial
100%
Flumazenil
100%
All Cause Mortality
18%
Benzodiazepine
12%
Observational Study
6%
Embase
6%
GABA Receptor
6%
SciSearch
6%